What Are EGFR Exon20 Insertions? 

""

EGFR Exon20 insertions are an epidermal growth factor (EGFR) mutation that occurs in about 2% of people with non-small cell lung cancer, or NSCLC.

What is NSCLC?

There are 2 main types of lung cancer:

""

Most people with lung cancer (about 8 in 10) have NSCLC, the same type as you

This is a rare mutation, but you're not alone.

Identifying your particular gene mutation can help you and your doctor choose specific treatment options—or targeted therapies—that are more likely to effectively treat your disease.

Treating EGFR Exon20 insertion mutations

The treatment of EGFR Exon20 insertion mutations is advancing and more treatment options are now available. This is a time of hope.

EXKIVITY® (mobocertinib) is helping to change the treatment story for people like you.

Learn About EXKIVITY

IMPORTANT SAFETY INFORMATION, INDICATION, AND USAGE

Expand+

What is the most important information I should know about EXKIVITY?

EXKIVITY may cause serious side effects, including changes in the electrical activity of your heart called QTc prolongation and Torsades de Pointes. QTc prolongation can cause irregular heartbeats that can be life-threatening and may lead to death. Your healthcare provider will check the electrical activity of your heart with a test called an electrocardiogram (ECG) and do blood tests to check your electrolytes before starting treatment and during treatment with EXKIVITY. Tell your healthcare provider right away if you feel dizzy, lightheaded, faint or have an irregular heartbeat. 

EXKIVITY may cause serious side effects, including:

  • Lung problems. EXKIVITY may cause severe lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you develop any new or worsening symptoms, including trouble breathing or shortness of breath, cough, chest pain, or fever.
  • Heart problems, including heart failure. EXKIVITY may cause heart problems that may lead to death. Your healthcare provider should check your heart function before you start and during treatment with EXKIVITY. Tell your healthcare provider right away if you have any signs or symptoms of a heart problem, including feeling like your heart is pounding or racing, shortness of breath, chest pain, swelling of your ankles and feet, or feeling faint.
  • Diarrhea. Diarrhea is common during treatment with EXKIVITY and may sometimes be severe. Diarrhea can cause you to lose too much body fluid (dehydration) and kidney problems. Your healthcare provider may tell you to start drinking more fluids and electrolytes to replace body salts or start taking your antidiarrheal medicines. Tell your healthcare provider right away if you have any loose stools or have stools more often than is normal for you.

The most common side effects of EXKIVITY include diarrhea, rash, nausea, mouth sores, vomiting, decreased appetite, infection of skin around nails, tiredness, dry skin, muscle or bone pain. EXKIVITY may affect fertility in females and males, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of EXKIVITY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking EXKIVITY, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, including a condition called long QTc syndrome
  • have problems with your electrolytes, such as sodium, potassium, calcium or magnesium
  • have lung or breathing problems other than lung cancer
  • are pregnant or plan to become pregnant. EXKIVITY can harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider should do a pregnancy test before you start treatment with EXKIVITY. You should use an effective form of non-hormonal birth control during treatment and for 1 month after your last dose of EXKIVITY. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not work as well during treatment with EXKIVITY. Talk to your healthcare provider about birth control methods that might be right for you during this time. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with EXKIVITY.

Males who have female partners who are able to become pregnant:

  • You should use effective birth control during treatment and for 1 week after your last dose of EXKIVITY.
  • are breastfeeding or plan to breastfeed. It is not known if EXKIVITY passes into your breast milk. Do not breastfeed during treatment and for 1 week after your last dose of EXKIVITY.

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you take medicines for heart problems. EXKIVITY and other medicines may affect each other causing serious side effects.

How should I take EXKIVITY?

Take EXKIVITY exactly as your healthcare provider tells you to take it.

  • Take your prescribed dose of EXKIVITY 1 time each day.
  • Take EXKIVITY with or without food.
  • Swallow EXKIVITY capsules whole. Do not open, chew, or dissolve the contents of the capsules.
  • Do not change your dose or stop taking EXKIVITY unless your healthcare provider tells you to.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with EXKIVITY if you develop certain side effects.
  • If you miss a dose of EXKIVITY, and it has been more than 6 hours, skip the dose and take your next dose at your regularly scheduled time the next day.
  • If you vomit a dose of EXKIVITY, do not take an extra dose. Take your next dose at your regularly scheduled time the next day.

What should I avoid while taking EXKIVITY?

  • Avoid eating grapefruit or drinking grapefruit juice during treatment with EXKIVITY. Grapefruit may increase the amount of EXKIVITY in your blood.

Please see Patient Information in the EXKIVITY (mobocertinib) full Prescribing Information.

 

What is EXKIVITY?

EXKIVITY is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):

  • that has spread to other parts of the body (metastatic) and cannot be removed by surgery, and
  • has a certain abnormal epidermal growth factor receptor (EGFR) gene, and
  • whose disease has worsened while on or after chemotherapy that contains platinum

Your healthcare provider will perform a test to make sure that EXKIVITY is right for you.

It is not known if EXKIVITY is safe and effective in children.

EXKIVITY is approved based on a medical study that measured how many people responded to treatment and for how long. There are ongoing studies to confirm its continued approval.

 

 

 

 

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about EXKIVITY?

EXKIVITY may cause serious side effects, including changes in the electrical activity of your heart called QTc prolongation and Torsades de Pointes. QTc prolongation can cause irregular heartbeats that can be life-threatening and may lead to death. Your healthcare provider will check the electrical activity of your heart with a test called an electrocardiogram (ECG) and do blood tests to check your electrolytes before starting treatment and during treatment with EXKIVITY. Tell your healthcare provider right away if you feel dizzy, lightheaded, faint or have an irregular heartbeat. 

EXKIVITY may cause serious side effects, including:

  • Lung problems. EXKIVITY may cause severe lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you develop any new or worsening symptoms, including trouble breathing or shortness of breath, cough, chest pain, or fever.
  • Heart problems, including heart failure. EXKIVITY may cause heart problems that may lead to death. Your healthcare provider should check your heart function before you start and during treatment with EXKIVITY. Tell your healthcare provider right away if you have any signs or symptoms of a heart problem, including feeling like your heart is pounding or racing, shortness of breath, chest pain, swelling of your ankles and feet, or feeling faint.
  • Diarrhea. Diarrhea is common during treatment with EXKIVITY and may sometimes be severe. Diarrhea can cause you to lose too much body fluid (dehydration) and kidney problems. Your healthcare provider may tell you to start drinking more fluids and electrolytes to replace body salts or start taking your antidiarrheal medicines. Tell your healthcare provider right away if you have any loose stools or have stools more often than is normal for you.

The most common side effects of EXKIVITY include diarrhea, rash, nausea, mouth sores, vomiting, decreased appetite, infection of skin around nails, tiredness, dry skin, muscle or bone pain. EXKIVITY may affect fertility in females and males, which may affect your ability to have a child. Talk to your healthcare provider if this is a concern for you.

These are not all the possible side effects of EXKIVITY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking EXKIVITY, tell your healthcare provider about all your medical conditions, including if you:

  • have heart problems, including a condition called long QTc syndrome
  • have problems with your electrolytes, such as sodium, potassium, calcium or magnesium
  • have lung or breathing problems other than lung cancer
  • are pregnant or plan to become pregnant. EXKIVITY can harm your unborn baby.

Females who are able to become pregnant:

  • Your healthcare provider should do a pregnancy test before you start treatment with EXKIVITY. You should use an effective form of non-hormonal birth control during treatment and for 1 month after your last dose of EXKIVITY. Birth control pills (oral contraceptives) and other hormonal forms of birth control may not work as well during treatment with EXKIVITY. Talk to your healthcare provider about birth control methods that might be right for you during this time. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with EXKIVITY.

Males who have female partners who are able to become pregnant:

  • You should use effective birth control during treatment and for 1 week after your last dose of EXKIVITY.
  • are breastfeeding or plan to breastfeed. It is not known if EXKIVITY passes into your breast milk. Do not breastfeed during treatment and for 1 week after your last dose of EXKIVITY.

Tell your healthcare provider about all the medicines you take, including prescription medicines and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you take medicines for heart problems. EXKIVITY and other medicines may affect each other causing serious side effects.

How should I take EXKIVITY?

Take EXKIVITY exactly as your healthcare provider tells you to take it.

  • Take your prescribed dose of EXKIVITY 1 time each day.
  • Take EXKIVITY with or without food.
  • Swallow EXKIVITY capsules whole. Do not open, chew, or dissolve the contents of the capsules.
  • Do not change your dose or stop taking EXKIVITY unless your healthcare provider tells you to.
  • Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with EXKIVITY if you develop certain side effects.
  • If you miss a dose of EXKIVITY, and it has been more than 6 hours, skip the dose and take your next dose at your regularly scheduled time the next day.
  • If you vomit a dose of EXKIVITY, do not take an extra dose. Take your next dose at your regularly scheduled time the next day.

What should I avoid while taking EXKIVITY?

  • Avoid eating grapefruit or drinking grapefruit juice during treatment with EXKIVITY. Grapefruit may increase the amount of EXKIVITY in your blood.

Please see Patient Information in the EXKIVITY (mobocertinib) full Prescribing Information.

 

What is EXKIVITY?

EXKIVITY is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):

  • that has spread to other parts of the body (metastatic) and cannot be removed by surgery, and
  • has a certain abnormal epidermal growth factor receptor (EGFR) gene, and
  • whose disease has worsened while on or after chemotherapy that contains platinum

Your healthcare provider will perform a test to make sure that EXKIVITY is right for you.

It is not known if EXKIVITY is safe and effective in children.

EXKIVITY is approved based on a medical study that measured how many people responded to treatment and for how long. There are ongoing studies to confirm its continued approval.